Curerite Pharma Private Limited - Company Profile

It is a business services private limited company based in Nagpur, Maharashtra, India, established in 2024.
2024 Nagpur, Maharashtra, India Active
Last Updated:
Access Report
About Curerite Pharma Private Limited

Curerite Pharma Private Limited, a active private limited company, was established on 07 February 2024 in Nagpur, Maharashtra, India. it holds CIN: U46497MH2024PTC418753. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Ruchi Lokesh Shadi (Director), Fagun Vijaykumar Shadi (Director). Past directors included Lokesh Vijay Shadi. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 41, Mahabir, Floor Mill, Nagpur, Maharashtra, 440018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497MH2024PTC418753

  • Registration Number

    418753

  • Incorporation Date

    07 February 2024

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 3 Days
  • Last Filing with ROC 31 Mar 2024
Company report

Curerite Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Curerite Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Curerite Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Ruchi Lokesh Shadi Director 07 Feb 2024 Current
Fagun Vijaykumar Shadi Director 09 May 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 10 May 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Curerite Pharma.

Enhance accessibility to Curerite Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Curerite Pharma revenue growth over time
Curerite Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Curerite Pharma?

Unlock access to Curerite Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Curerite Pharma?

Unlock and access historical data on people associated with Curerite Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Curerite Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curerite Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Curerite Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Curerite Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    The activity Fagun Vijaykumar Shadi was appointed as a Director was appointed as a Director on 09 May 2024 & has been associated with this company since 1 year 9 months . was completed.

  • Balance Sheet

    The activity Curerite Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.

  • Director Appointment

    Progress on Ruchi Lokesh Shadi was appointed as a Director was appointed as a Director on 07 Feb 2024 & has been associated with this company since 2 years 3 days . was documented.

  • Company Incorporation

    Progress on Curerite Pharma Private Limited was registered on 07 Feb 2024 with Roc Mumbai & aged 2 years 3 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Curerite Pharma Private Limited?

The CIN of Curerite Pharma Private Limited is U46497MH2024PTC418753.

Where is Curerite Pharma Private Limited headquartered?

Curerite Pharma Private Limited is headquartered at Plot No 41, Mahabir, Floor Mill, Nagpur, Maharashtra, 440018.

When was Curerite Pharma Private Limited incorporated?

Curerite Pharma Private Limited was incorporated on 07 February 2024.

Who are the current directors of Curerite Pharma Private Limited?

The current directors of Curerite Pharma Private Limited are

Is Curerite Pharma Private Limited a listed company?

Curerite Pharma Private Limited is unlisted.

What is the capital structure of Curerite Pharma Private Limited?

The authorized capital of Curerite Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available